Thromb Haemostasis
-
Randomized Controlled Trial Multicenter Study Comparative Study Clinical Trial
Risk factors for bleeding during treatment of acute venous thromboembolism.
Identification of risk factors for bleeding and prospective evaluation of two bleeding risk scores in the treatment of acute venous thromboembolism. ⋯ A small body surface area and malignancy were associated with a higher frequency of bleeding. The bleeding risk scores merely offer the clinician a general estimation of the risk of bleeding. In patients with a small body surface area or in patients with malignancy, it may be of interest to study whether limited dose reduction of the anticoagulant drug may cause less bleeding without affecting efficacy.